Publications
2 shownCombined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
A combination of dabrafenib and trametinib, as compared with dabrafenib alone, improved the rate of progression-free survival in previously untreated patients who had metastatic...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,503
- Institution
- Harvard Stem Cell Institute
External Links
Identifiers
- ORCID
- 0000-0001-5316-0241
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.